Sedasys, a Division of Ethicon Endo-Surgery, Inc. (Ethicon), today announced that the U.S. Food and Drug Administration (FDA) has granted PMA approval for the SEDASYS System, the first computer-assisted personalized sedation (CAPS) system.


Giving palliative radiotherapy to elderly patients with painful bone metastases can significantly improve their quality of life, a Dutch researcher told the 2nd Forum of the European Society for Radiotherapy and Oncology (ESTRO) recently.

The Remote Mobile Anesthesia System, initially developed for use in proton treatment centers but useful in any medical setting, provides the ability to administer anesthesia to a patient before, during and after proton therapy treatment without interruption, reducing preparation and treatment time by as much as 30 percent.

Saving lives is no longer enough. Patients need to be satisfied. You might thank the recession for that.

Since the downturn, retailers have been treating customers like … people. Stores from Walmart to Menards walk customers with questions to their answers. The folks at Festival Foods smile good morning, good afternoon and good evening to passing shoppers. It’s as if they actually want customers to be there. Now, medical centers, hospitals and clinics are catching on.

UltraSPECT has announced its distribution agreement with PharmaLogic for the sale of UltraSPECT’s cardiac and bone imaging applications. The agreement will enable PharmaLogic to provide its hospitals and imaging centers with access to UltraSPECT’s Xpress line of products for lower radiation dose with no diminished image quality.

Scranton Gillette Communications’ sister publications Imaging Technology News and Diagnostic and Interventional Cardiology were honored with American Society of Healthcare Publication Editors (ASHPE) 2013 awards, in recognition of editorial excellence and achievement in the field of healthcare publishing.

Researchers at New York University and NYU Langone Medical Center have created a novel way to enhance magnetic resonance imaging (MRI) by reducing interference from large macromolecules that can often obscure images generated by current chemical exchange saturation transfer (CEST) methods.

Inflammatory bowel diseases (IBD), such as Crohn's disease and ulcerative colitis, may be detected and monitored more effectively in the future with positron emission tomography/computed tomography (PET/CT), according to research published in the May issue of The Journal of Nuclear Medicine. Typically assessed by endoscopic and histologic evaluations, investigators demonstrated the ability of PET/CT to identify lesions along the complete intestinal wall that could be missed with traditional imaging techniques.

 

May 2, 2013 — Elekta and Royal Philips Electronics announced that the Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital (NKI-AVL, Amsterdam, the Netherlands) has signed an agreement to join a research group to advance the development of an image-guided treatment technology for cancer care.
Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now